Exchange Traded Concepts’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62,752
| Closed | -$112K | – | 1446 |
|
|
2025
Q1 | $112K | Sell |
62,752
-14,598
| -19% | -$26K | ﹤0.01% | 1115 |
|
|
2024
Q4 | $143K | Hold |
77,350
| – | – | ﹤0.01% | 1064 |
|
|
2024
Q3 | $177K | Sell |
77,350
-8,887
| -10% | -$20.4K | ﹤0.01% | 996 |
|
|
2024
Q2 | $167K | Sell |
86,237
-26,833
| -24% | -$52.1K | ﹤0.01% | 893 |
|
|
2024
Q1 | $326K | Buy |
113,070
+66,182
| +141% | +$191K | 0.01% | 772 |
|
|
2023
Q4 | $131K | Buy |
46,888
+11,890
| +34% | +$33.3K | ﹤0.01% | 850 |
|
|
2023
Q3 | $88.5K | Sell |
34,998
-7,433
| -18% | -$18.8K | ﹤0.01% | 945 |
|
|
2023
Q2 | $133K | Buy |
+42,431
| New | +$133K | ﹤0.01% | 879 |
|